New drug CLYM116 begins first human safety tests
NCT ID NCT07248865
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This early-stage study is testing a new drug, CLYM116, in 48 healthy adults aged 18 to 60. The main goal is to see if the drug is safe and how the body processes it after one or several injections under the skin. Participants will be randomly assigned to receive either the drug or a placebo, and no one will know which they got.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network Brisbane
RECRUITINGBrisbane, 4006, Australia
Conditions
Explore the condition pages connected to this study.